Dose-finding, Safety and Efficacy Study of NV1FGF in Patients With Intermittent Claudication

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions

Peripheral Arterial Occlusive Disease

Interventions

DRUG

XRP0038 (NV1FGF)

"Pharmaceutical form:solution~Route of administration: intramuscular"

DRUG

placebo

"Pharmaceutical form:solution~Route of administration: intramuscular"

Trial Locations (4)

Minneapolis

Brussels

Münster

Bern